Search Results
Dr Rugo on Elacestrant-Based Combinations in ER+/HER2– Metastatic Breast Cancer
Dr. Hope Rugo – ESMO 2022 – Exploring the latest trial data & advances in breast cancer treatments
Dr. Rugo on Ongoing Trials in HER2+ Breast Cancer
Dr. Rugo on 20-Year Span of Breast Cancer Advancements
Dr. Rugo on the Phase III SOPHIA Trial in HER2+ Breast Cancer
Optimizing Therapy in HER2+ Disease with Dr. Hope S. Rugo
Dr. Hope Rugo Examines Angiogenesis Inhibition for Advanced Breast Cancer
Hope Rugo, MD: Advances and Challenges In the Treatment of Metastatic Breast Cancer
Dr. Rugo on Guidelines for the Treatment of Metastatic Breast Cancer
Dr. Rugo Discusses MONARCH I in HR+ HER2- Breast Cancer
Dr. Hope Rugo on Safety of Trastuzumab Biosimilar for HER2+ Breast Cancer
Optimizing treatment in patients with early-stage HER2-positive breast cancer
